Video | April 30, 2020

Biopharmaceutical Company Fundraising And Investor Meetings During COVID-19

Source: Life Science Leader

Rob Wright, chief editor of Life Science Leader, recently moderated a COVID-19 leadership roundtable with five biopharmaceutical CEOs via Zoom (view in full here). In this clip, five biopharma CEOs share insight gained from fundraising and meeting with investors during the coronavirus pandemic. Appearing in this video (in order) are:

  • Leen Kawas, Ph.D., Pharm.D., CEO, Athira Pharma 
  • Caroline Loew, Ph.D., CEO, Glympse Bio
  • Mike Clayman, M.D., CEO, Flexion Therapeutics
  • Paul Wotton, Ph.D., CEO, Obsidian Therapeutics
  • Rachel Leheny, Ph.D., CEO, CalciMedica